Multisystem inflammatory syndrome in children (MIS‐C) is a rare, but severe complication of
coronavirus disease 2019 (COVID‐19). It develops approximately 4 weeks after severe …

Multisystem inflammatory syndrome in children (MIS-C) is defined as a clinically serious
condition requiring hospitalization involving fever, multi-system organ dysfunction, and an …

SARS-CoV-2 infection in children is associated with lower morbidity and mortality than in
adults, with many children experiencing mild symptoms or entirely asymptomatic disease. In …

Multisystem inflammatory syndrome in children (MIS‐C) during the COVID‐19 pandemic
raised a global alert from the Centers for Disease Control and Prevention's Health Alert …

Background Multisystem inflammatory syndrome in children (MIS-C) is a serious health
condition that develops from and is linked to coronavirus disease 2019. MIS-C is considered …

Multisystem inflammatory syndrome in children (MIS-C) is a rare complication of SARS-CoV-
2 infection that can result in serious illness in the paediatric population but our …

PURPOSE: The pandemic caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has infected over 43 million people resulting in over 1 million deaths …

Background: Following the spread of the coronavirus disease 2019 (COVID-19) pandemic a
new disease entity emerged, defined as Pediatric Inflammatory Multisystem Syndrome …

We report three critically ill pediatric patients (aged 6–10 years), presenting with features of
multisystem inflammatory syndrome in children (MIS‐C) from April 4 to May 10, 2020, to a …

As of May 2020, an emerging immune-mediated syndrome mainly affecting children has
been detected primarily in Europe and the United States. The incidence of this syndrome …